Guanylhydrazone salts, compositions, processes of making,...

Details Guanylhydrazone salts, compositions, processes of making,... Guanylhydrazone salts, compositions, processes of making,...

2007-06-22

2011-10-11

Katakam, Sudhakar (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

C514S616000, C564S152000

Reexamination Certificate

active

08034840

ABSTRACT:
The invention relates to pharmaceutically acceptable salts of guanylhydrazone-containing compounds, for example, Semapimod. The invention also relates to pharmaceutically acceptable compositions comprising the salts and methods for their use.

REFERENCES:
patent: 4321253 (1982-03-01), Beatty
patent: 4482722 (1984-11-01), Thorbek et al.
patent: 4572909 (1986-02-01), Campbell et al.
patent: 4704397 (1987-11-01), Fisher et al.
patent: 4791196 (1988-12-01), Ide et al.
patent: 5028625 (1991-07-01), Motola et al.
patent: 5272165 (1993-12-01), Ulrich et al.
patent: 5599984 (1997-02-01), Bianchi et al.
patent: 5599986 (1997-02-01), Evans et al.
patent: 5690954 (1997-11-01), Illum
patent: 5750573 (1998-05-01), Bianchi et al.
patent: 5753684 (1998-05-01), Bianchi et al.
patent: 5849794 (1998-12-01), Bianchi et al.
patent: 5854289 (1998-12-01), Bianchi et al.
patent: 5859062 (1999-01-01), Bianchi et al.
patent: 5980952 (1999-11-01), De Barochez et al.
patent: 5993858 (1999-11-01), Crison et al.
patent: 6008255 (1999-12-01), Bianchi et al.
patent: 6022900 (2000-02-01), Bianchi et al.
patent: 6028054 (2000-02-01), Benet et al.
patent: 6143728 (2000-11-01), Tracey et al.
patent: 6180676 (2001-01-01), Bianchi et al.
patent: 6248787 (2001-06-01), Bianchi et al.
patent: 6255502 (2001-07-01), Penkler et al.
patent: 6277405 (2001-08-01), Stamm et al.
patent: 6319894 (2001-11-01), Tracey et al.
patent: 6576651 (2003-06-01), Bandyopadhyay et al.
patent: 6673777 (2004-01-01), Tracey et al.
patent: 6689777 (2004-02-01), Ulrich et al.
patent: 7244765 (2007-07-01), Sielecki-Dzurdz
patent: 2002/0028851 (2002-03-01), Bianchi et al.
patent: 2003/0040464 (2003-02-01), Wong et al.
patent: 2003/0096761 (2003-05-01), Burnside et al.
patent: 2003/0134904 (2003-07-01), Giordano et al.
patent: 2003/0139446 (2003-07-01), Chen et al.
patent: 2003/0144510 (2003-07-01), Gala et al.
patent: 2003/0181487 (2003-09-01), Kamiyama et al.
patent: 2003/0191176 (2003-10-01), Dunn et al.
patent: 2003/0198669 (2003-10-01), Cutler et al.
patent: 2003/0203969 (2003-10-01), Bevec et al.
patent: 2004/0043079 (2004-03-01), D'Souza
patent: 2008/0146670 (2008-06-01), Sielecki-Dzurdz
patent: 1389480 (2004-02-01), None
patent: 9519767 (1995-07-01), None
patent: 0200613 (2002-01-01), None
patent: 03006426 (2003-01-01), None
patent: 03072135 (2003-09-01), None
Berge et al., {Journal of Pharmaceutical Sciences, Pharmaceutical Salts, vol. 66, Jan. 1, 1977, 1-19}.
Engel et al., {Salt form Selection and Characterization of LY333531 Mesylate Monohydrate, International Journal of Pharmaceutics 198, 2000, 239-247}.
Tong et al., {In Situ Salt Screening—A useful Technique for Discovery Support and Performance Studies}, Pharmaceutical Development and Technology, 3(2), 215-223, (1998)}.
Magali Sautel, Patrick Dorion, Benoit Robert, My Truong. Salt and Polymorph Selection: Fundamental Topics in any Pharmaceutical Development. Analytical Sciences Department, Longjumeau, France, Jul. 12, 2003.
M.J. D'Souza, C.W. Oettinger, G.V. Milton, K.J. Tracey. Prevention of Lethality and Suppression of Proinflammatory Cytokines in Experimental Septic Shock by Microencapsulated CNI-1493. Journal of Interferon and Cytokine Research, 1999, 19:1125-1133.
Marc Stranz, Eric S. Kastango, A Review of pH and Osmolarity. International Journal of Pharmaceutical Compounding, vol. 6 No. 3, 216-220, May/Jun. 2002.
Gary L. Engel, Nagy A. Farid, Margaret M. Paul, Lori A. Richardson, Leonard L. Winneroski, Salt form selection and characterization of LY333531 mesylate monohydrate. International Journal of Pharmaceutics 198 (2000):239-247.
Emily C. Ware, D. Robert Lu, An automated approach to salt selection for new unique trazodone salts. Pharmaceutical Research, Jan. 2004, vol. 21(1):177-184.
Wei-Qin (Tony) Tong, Graham Whitesell, in situ salt screening-a useful technique for discovery support and preformulation studies. Pharmaceutical Development and Technology 3(2),215-223 (1998).
Abu T. M. Serajuddin, Pai-Chang Sheen, Daniel Mufson, David F. Bernstein, Matthew A. Augustine . Preformulation study of a poorly water-soluble drug, alpha-Pentyl-3-(2-quinolinylmethoxy) benzenemethanol: Selection of the base for dosage form design. J. Pharm. Sci. May 1986;75(5):492-496.
Lian-Feng Huang, Wei-Qin (Tony) Tong, Impact of solid state properties on developability assessment of drug candidates. Advanced Drug Delivery Reviews 56 (2004) 321-334.
PCT/US05/22626 Notification of Transmittal of the International Search Report, dated Feb. 21, 2006.
PCT/US05/22626 Written Opinion of the International Searching Authority dated Feb. 21, 2006.
Marc Stranz, et al. “A Review of pH and Osmolarity” Intl. Jnl. of Pharm. Compounding, vol. 6, No. 3, pp. 216-220, 2002.
PCT/US05/22626, International Search Report, dated Feb. 21, 2006.
PCT/US05/22626, Written Opinion of the International Searching Authority, dated Feb. 21, 2006.
Examiner's First Report, Jul. 19, 2010, 3 pp.; Australian Application No. 2005260126.
First Office Action, Mar. 27, 2009, 5 pp.; Chinese Application No. 200580020239.4.
Examiner Communication, Sep. 16, 2010, 4 pp.; European Application No. 05763891.8.
First Examination Report, Jul. 15, 2010; 2 pp.; Indian Application No. 1378/MUMNP/2006.
Notice of Reasons for Rejection (Translation), Jul. 27, 2010; 5 pp.; Japanese Application No. 2007-518339.
First Office Action, Oct. 26, 2010; 2 pp.; Mexican Application No. PA/a/2006/015058; and Translation of Relevant Portion.
Office Action, Sep. 9, 2010, 16 pp.; U.S. Appl. No. 11/931,738.
Office Action, Mar. 25, 2011, 12 pp.; U.S. Appl. No. 11/931,738.
Berge et al., Journal of Pharmaceutical Sciences, Pharmaceutical Salts; vol. 66, Jan. 1, 1997, pp. 1-19.

Affiliated with

Also associated with

Rating

Guanylhydrazone salts, compositions, processes of making,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Guanylhydrazone salts, compositions, processes of making,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Guanylhydrazone salts, compositions, processes of making,... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4287433